Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins	11/81	1.6331520385016347E-8	9.16198293599417E-6	0	0	11.522441364605545	206.5993190069169	NDUFA8;COX7B;UQCRB;NDUFA4;UQCRQ;UCP1;ATP5C1;UQCRC2;SDHB;ATP5J2;COX6B1
Tricarboxylic acid (TCA) cycle and respiratory electron transport	12/117	8.948252157039337E-8	2.5099847300495338E-5	0	0	8.396361690743714	136.26642224129003	NDUFA8;COX7B;UQCRB;UQCRQ;NDUFA4;UCP1;ATP5C1;SUCLG1;UQCRC2;SDHB;ATP5J2;COX6B1
Electron transport chain	11/105	2.4972208140752816E-7	4.669802922320777E-5	0	0	8.57006192442045	130.28994193715485	NDUFA8;COX7B;UQCRB;UQCRQ;NDUFA4;UCP1;ATP5C1;UQCRC2;SDHB;ATP5J2;COX6B1
Influenza viral RNA transcription and replication	11/125	1.4532357324007653E-6	2.0381631146920733E-4	0	0	7.059341450641529	94.88967667907707	RPS27;RPL10;RPS29;EIF4A3;RPS3;RPL23A;RPS2;RPL39;UBA52;POLR2J;POLR2L
Huntington's disease	13/184	1.977868255984868E-6	2.219168183215022E-4	0	0	5.587433496020753	73.38250715113436	NDUFA8;COX7B;UQCRB;NDUFA4;UCP1;ATP5C1;SDHB;COX6B1;UQCRQ;UQCRC2;POLR2J;TGM2;POLR2L
Oxidative phosphorylation	11/136	3.3333687548917356E-6	3.116699785823773E-4	0	0	6.434507462686567	81.148965416018	NDUFA8;COX7B;ATP6V1G2;UQCRB;UQCRQ;NDUFA4;ATP5C1;UQCRC2;SDHB;ATP5J2;COX6B1
Protein metabolism	19/442	1.57045548164468E-5	0.001258607893146665	0	0	3.3338970721949446	36.878101737740785	CCT3;TRAM1;SEC13;SSR4;RPL10;GALNT18;DOLK;RPL23A;TUBB4B;DPM3;RPS27;RPS29;DAD1;RPS3;MAN1C1;RPS2;RPL39;UBA52;B4GALT5
Influenza infection	10/142	3.1306103065006855E-5	0.0021953404774336057	0	0	5.516784949870452	57.21842463577358	RPS27;RPL10;RPS29;RPS3;RPL23A;RPS2;RPL39;UBA52;POLR2J;POLR2L
Translation	10/151	5.2900344388441706E-5	0.0032974548002128665	0	0	5.162276885760236	50.83346038152829	TRAM1;RPS27;SSR4;RPL10;RPS29;RPS3;RPL23A;RPS2;RPL39;UBA52
Parkinson's disease	9/131	9.430297860026796E-5	0.005290397099475033	0	0	5.354918032786885	49.634723370806284	NDUFA8;COX7B;UQCRB;UQCRQ;NDUFA4;ATP5C1;UQCRC2;SDHB;COX6B1
Alzheimer's disease	10/169	1.3544619008634193E-4	0.006400356273720032	0	0	4.573659722709312	40.73729497404983	NDUFA8;COX7B;UQCRB;UQCRQ;NDUFA4;ATP5C1;CHP1;UQCRC2;SDHB;COX6B1
Cytoplasmic ribosomal proteins	8/108	1.3690601655016112E-4	0.006400356273720032	0	0	5.792177121771218	51.52845807965311	RPS27;RPL10;RPS29;RPS3;RPL23A;RPS2;RPL39;UBA52
Metabolism	38/1615	0.0010369761798659641	0.04474951053113891	0	0	1.8141278808178773	12.465682351079717	COX7B;ACADVL;UQCRB;GALNT18;APIP;ATP5C1;MAN1C1;POLR2J;TRDMT1;POLR2L;NDUFA8;ATP6V1G2;GSTM1;NDUFA4;MBOAT7;NME2;DOLK;HS3ST5;GNG12;SDHB;PAFAH2;ATP5J2;COX6B1;COQ3;DPM3;UQCRQ;DAD1;LPCAT3;POLR1C;POLE3;BLVRB;SUCLG1;UQCRC2;FAR2;PHPT1;GCLM;ITPA;B4GALT5
Asparagine N-linked glycosylation	6/85	0.0012152085318724035	0.0486951418843156	0	0	5.464459591041869	36.68204065745453	SEC13;DPM3;DAD1;MAN1C1;DOLK;B4GALT5
p75 neurotrophin receptor signaling via NF-kB	3/16	0.001314527735026268	0.04916333728998242	0	0	16.47826086956522	109.32136051211945	NGFR;IRAK1;UBA52
Protein processing in the endoplasmic reticulum	8/166	0.0023477008580501607	0.08231626133538376	0	0	3.65509832313513	22.12913044977151	TRAM1;SEC13;SSR4;DAD1;FBXO2;DNAJC5;MAN1C1;HSPBP1
Pyrimidine metabolism	6/100	0.0027858023557538413	0.09193147773987677	0	0	4.5889642272621	26.99788312948223	POLR1C;POLE3;NME2;POLR2J;ITPA;POLR2L
Sulfur amino acid metabolism	3/24	0.00437567649809049	0.13150705308087168	0	0	10.196687370600413	55.38528706880351	APIP;SLC25A10;GCLM
N-glycan biosynthesis	4/48	0.00445389306334503	0.13150705308087168	0	0	6.504793388429752	35.21679997052553	DPM3;DAD1;MAN1C1;DOLK
Peroxisome	5/78	0.004697591583848699	0.131767443926956	0	0	4.911508849115089	26.329151668598282	PECR;PEX11B;MPV17;FAR2;PEX14
Cardiac muscle contraction	5/80	0.005230687864783998	0.13973409010208682	0	0	4.780048661800486	25.110611316967013	COX7B;UQCRB;UQCRQ;UQCRC2;COX6B1
PI3K/AKT signalling	2/9	0.006543357636644159	0.16685561973442606	0	0	20.334192882929344	102.2668547885198	NTRK1;MTOR
RNA polymerase	3/29	0.007505206049860733	0.17698614637633509	0	0	8.233695652173912	40.28054301240319	POLR1C;POLR2J;POLR2L
TRAF6-mediated IRF7 activation in TLR7/8 or 9 signaling	2/10	0.00810427583890057	0.17698614637633509	0	0	17.791516245487365	85.6726174976294	IRAK1;UBE2V1
IKK complex recruitment by IRAK1	2/10	0.00810427583890057	0.17698614637633509	0	0	17.791516245487365	85.6726174976294	IRAK1;UBE2V1
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	4/57	0.008202566498724978	0.17698614637633509	0	0	5.397735849056604	25.926988789817145	RPS27;RPS29;RPS3;RPS2
T cell receptor regulation of apoptosis	16/603	0.010892740391875983	0.2263269392534232	0	0	1.9830419546446778	8.96267288371416	IL15RA;TRAP1;BNIP3;SHISA5;ATP5C1;VEZF1;SLC3A2;RRAGA;CENPF;HAX1;RPS29;CASP6;DAD1;MAP4K5;TMEM9B;CNIH4
Transport to the Golgi and subsequent modification	3/36	0.01365491401010474	0.26436216971138654	0	0	6.484848484848484	27.843707447838216	SEC13;MAN1C1;B4GALT5
Chemiosmotic coupling formation of ATP	2/13	0.013665780608966505	0.26436216971138654	0	0	12.937315392189038	55.53808810841058	ATP5C1;ATP5J2
Viral messenger RNA biosynthesis	2/14	0.015798038943076558	0.29542332823553163	0	0	11.858604091456076	49.18794179874158	POLR2J;POLR2L
Cap-dependent translation initiation	4/73	0.019028940118779814	0.3219176349273714	0	0	4.1427140974967065	16.41258107523747	RPL10;RPL23A;RPL39;UBA52
Post-translational protein modification	7/196	0.020385817213368275	0.3219176349273714	0	0	2.6595860566448803	10.353544726475445	SEC13;DPM3;DAD1;GALNT18;MAN1C1;DOLK;B4GALT5
Cell death signaling by NRIF in the nucleus	2/16	0.0204550650156011	0.3219176349273714	0	0	10.163486333161423	39.53113163033645	NGFR;UBA52
Inhibitor of DNA binding (ID) signaling pathway	2/16	0.0204550650156011	0.3219176349273714	0	0	10.163486333161423	39.53113163033645	ELK4;ID3
N-glycan precursor substrate biosynthesis	2/16	0.0204550650156011	0.3219176349273714	0	0	10.163486333161423	39.53113163033645	DPM3;DOLK
Messenger RNA splicing: minor pathway	3/42	0.02065781614507196	0.3219176349273714	0	0	5.4855072463768115	21.28191141093787	SNRPG;POLR2J;POLR2L
Mitochondrial pathway of apoptosis: caspases	4/77	0.02266810325211421	0.3436974574171911	0	0	3.9149190535491907	14.825001713829941	CASP6;APIP;HSPB1;LAMTOR5
Purine metabolism	6/164	0.027739929454363377	0.4079770745340399	0	0	2.7212407845319238	9.755328214224223	POLR1C;POLE3;NME2;POLR2J;ITPA;POLR2L
ER-associated degradation (ERAD) pathway	2/19	0.028362042614665874	0.4079770745340399	0	0	8.368655765555319	29.81503965000729	FBXO2;MAN1C1
p75 neurotrophin receptor-mediated signaling	5/124	0.030037609008714557	0.4212774663472217	0	0	3.005888486781574	10.536556088961497	NTRK1;NGFR;IRAK1;CASP6;UBA52
Signaling by Hippo	2/20	0.031228057820039946	0.4272912301717661	0	0	7.903329322101885	27.396403453174507	MOB1A;DVL2
Y branching of actin filaments	2/21	0.0342030912245543	0.456855575642261	0	0	7.486984609538286	25.27186173251632	NTRK1;ARPC1B
RNA polymerase III transcription termination	2/23	0.04046598709110697	0.5044759724024669	0	0	6.773250816572117	21.72380320021747	POLR1C;POLR2L
Deadenylation of mRNA	2/23	0.04046598709110697	0.5044759724024669	0	0	6.773250816572117	21.72380320021747	CNOT6;EIF4A3
Mitochondrial fatty acid beta-oxidation	2/23	0.04046598709110697	0.5044759724024669	0	0	6.773250816572117	21.72380320021747	PECR;ACADVL
Regulatory RNA pathways	2/25	0.04712304963722351	0.5524054666072237	0	0	6.183644639773976	18.89099121934174	POLR2J;POLR2L
Glutathione conjugation	2/25	0.04712304963722351	0.5524054666072237	0	0	6.183644639773976	18.89099121934174	GSTM1;GCLM
Nucleotide excision repair	3/58	0.047264638854094	0.5524054666072237	0	0	3.8865612648221344	11.861757214674201	POLE3;POLR2J;POLR2L
Disease	15/674	0.051615286513259695	0.5680104832505314	0	0	1.6435025520761484	4.871238681276523	CALCA;ACADVL;ATP6V1G2;RPL10;RPL23A;MTOR;RPS27;RPS29;RPS3;RPS2;STX2;RPL39;UBA52;POLR2J;POLR2L
RNA polymerase III transcription initiation from type 2 promoter	2/27	0.054147798717709396	0.5680104832505314	0	0	5.688375451263538	16.587518734826208	POLR1C;POLR2L
Cooperation of prefoldin and TriC/CCT  in actin and tubulin folding	2/27	0.054147798717709396	0.5680104832505314	0	0	5.688375451263538	16.587518734826208	CCT3;TUBB4B
RNA polymerase III transcription initiation From type 3 promoter	2/28	0.05779009782812359	0.5680104832505314	0	0	5.469314079422382	15.592674445078956	POLR1C;POLR2L
Dual incision reaction in TC-NER	2/28	0.05779009782812359	0.5680104832505314	0	0	5.469314079422382	15.592674445078956	POLR2J;POLR2L
Messenger RNA capping	2/28	0.05779009782812359	0.5680104832505314	0	0	5.469314079422382	15.592674445078956	POLR2J;POLR2L
DNA repair	4/105	0.0594996480842109	0.5680104832505314	0	0	2.8255625562556257	7.973129701559354	ALKBH3;UBA52;POLR2J;POLR2L
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	2/30	0.06531924234075888	0.5680104832505314	0	0	5.078133058277462	13.855526647621478	DPM3;DOLK
p38-alpha and p38-beta regulation	2/30	0.06531924234075888	0.5680104832505314	0	0	5.078133058277462	13.855526647621478	CCM2;PAK3
O-glycan biosynthesis	2/30	0.06531924234075888	0.5680104832505314	0	0	5.078133058277462	13.855526647621478	GALNT18;B4GALT5
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	7/255	0.0671623939452791	0.5680104832505314	0	0	2.020739444971537	5.457293416050264	ANAPC13;SEC13;FBXO2;UBE2V1;UBA52;ASB3;TRIM11
Phospholipase C delta-1 interactions in phospholipid-associated cell signaling	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	TGM2
Acyl chain remodeling of diacylglycerol and triacylglycerol	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	PNPLA2
Axonal growth stimulation	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	NGFR
Beta-oxidation of myristoyl-CoA to lauroyl-CoA	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	ACADVL
Sulfide oxidation to sulfate	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	SLC25A10
Heme degradation	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	BLVRB
Kit receptor transcriptional targets	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	BNIP3
N-glycan trimming and elongation in the cis-Golgi	1/5	0.0678372591404378	0.5680104832505314	0	0	17.73111510791367	47.70811298418376	MAN1C1
Activated NOTCH1 signaling in the nucleus	2/31	0.0692001703776259	0.5709014056154136	0	0	4.902776048798706	13.094098713614162	MIB2;UBA52
FSH regulation of apoptosis	7/263	0.07634448103483894	0.5827922241819863	0	0	1.956787109375	5.033833928963254	RAB1A;YTHDF2;DNAJC5;TYRO3;PRKX;IFI35;RPRM
Activation of TRKA receptors	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	NTRK1
Cell cycle negative regulation by p75 neurotrophin receptor	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	NGFR
eIF4E release	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	MTOR
Methionine salvage pathway	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	APIP
NADE-dependent death signaling	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	NGFR
NF-kappaB activation	1/6	0.08084415615087263	0.5827922241819863	0	0	14.184172661870504	35.67648462811393	IRAK1
Cysteine and methionine metabolism	2/34	0.08127425158882715	0.5827922241819863	0	0	4.442463898916968	11.150255738202839	APIP;TRDMT1
TOR signaling	2/34	0.08127425158882715	0.5827922241819863	0	0	4.442463898916968	11.150255738202839	RRAGA;MTOR
Fatty acid beta oxidation	2/34	0.08127425158882715	0.5827922241819863	0	0	4.442463898916968	11.150255738202839	ACADVL;PNPLA2
Signaling by NOTCH1	3/73	0.08206878023240093	0.5827922241819863	0	0	3.0513975155279502	7.629096744902012	KAT2A;MIB2;UBA52
Gene expression	19/968	0.08501910411736589	0.5961964676230284	0	0	1.4455216016859853	3.5630362641919233	RARS2;TRAM1;SSR4;RPL10;EIF4A3;HSPB1;RPL23A;KAT2A;CNOT6;RPS27;RPS29;POLR1C;RPS3;SNRPG;RPS2;RPL39;UBA52;POLR2J;POLR2L
SNARE interactions in vesicular transport	2/36	0.08965588277234554	0.6070369275296766	0	0	4.18071777447441	10.082956721740786	STX2;USE1
PI3K/PLC/TRK pathway	2/36	0.08965588277234554	0.6070369275296766	0	0	4.18071777447441	10.082956721740786	NTRK1;TRPV1
Phase I of biological oxidations: non-cytochrome P450 enzymes	1/7	0.0936702052860262	0.6070369275296766	0	0	11.819544364508394	27.988386986969154	ESD
Ubiquinone and other terpenoid-quinone biosynthesis	1/7	0.0936702052860262	0.6070369275296766	0	0	11.819544364508394	27.988386986969154	COQ3
PI3K/AKT activation	2/37	0.09393854173788635	0.6070369275296766	0	0	4.061062403300671	9.604877664140924	NTRK1;MTOR
Interleukin-1 signaling pathway	4/125	0.09785876102845384	0.6070369275296766	0	0	2.3561232156273477	5.476172388345981	ELK4;IRAK1;HSPB1;UBE2V1
p38 alpha/beta MAPK downstream pathway	2/38	0.09827908827085222	0.6070369275296766	0	0	3.9480545527476933	9.159265503794593	ELK4;HSPB1
Apoptosis modulation and signaling	3/80	0.10118475050064549	0.6070369275296766	0	0	2.7730095990965555	6.352430411393226	IRAK1;CASP6;BNIP3
Tricarboxylic acid (TCA) cycle	2/39	0.10267508821972908	0.6070369275296766	0	0	3.8411552346570397	8.743182846793678	SUCLG1;SDHB
FAS pathway and stress induction of heat shock protein regulation	2/39	0.10267508821972908	0.6070369275296766	0	0	3.8411552346570397	8.743182846793678	CASP6;HSPB1
HIV-1 transcription initiation	2/39	0.10267508821972908	0.6070369275296766	0	0	3.8411552346570397	8.743182846793678	POLR2J;POLR2L
Aflatoxin B1 metabolism	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	GSTM1
S6K1 signaling	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	MTOR
Cytoskeletal remodeling regulation and cell spreading by IPP complex components	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	RSU1
Degradation of cysteine and homocysteine	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	SLC25A10
Thiamine metabolism	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	PHPT1
Downregulation of ERBB4 signaling	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	UBA52
Mitochondrial beta-oxidation of saturated fatty acids	1/8	0.10631791157018673	0.6070369275296766	0	0	10.130524152106887	22.70576166577243	ACADVL
Pyruvate metabolism and citric acid (TCA) cycle	2/40	0.10712416368170764	0.6070369275296766	0	0	3.739882196465894	8.354024346171547	SUCLG1;SDHB
C-Myb transcription factor network	3/85	0.11582077843743904	0.6173026553311283	0	0	2.6032608695652173	5.611878863243436	SLC25A3;GSTM1;CASP6
Axonogenesis regulation by p75 neurotrophin receptor	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	NGFR
COPII-mediated vesicle transport	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	SEC13
Calcium-activated potassium channels	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	KCNMB2
Calcium/calmodulin-dependent protein kinase activation	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	CAMK1
West Nile virus infection	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	CASP6
Folding of actin by CCT/TriC	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	CCT3
Opsins	1/9	0.11878974561639767	0.6173026553311283	0	0	8.863758992805755	18.883353861350294	RHO
Glycerophospholipid biosynthesis	3/86	0.11883901386053805	0.6173026553311283	0	0	2.571765322158198	5.477822913662657	MBOAT7;LPCAT3;PNPLA2
Mitotic prometaphase	2/43	0.12076688455687817	0.6215616718936574	0	0	3.4657039711191335	7.326127938285303	CENPF;RPS27
Apoptosis	6/242	0.12375238435376866	0.6285508446561279	0	0	1.8145837213633824	3.7915229847285308	NTRK1;IRAK1;CASP6;CHP1;PRKX;UBA52
Vasopressin-regulated water reabsorption	2/44	0.12540556955542015	0.6285508446561279	0	0	3.383015299982809	7.0238239351588545	DCTN6;PRKX
RNA polymerase III transcription	2/45	0.13008624628376658	0.6285508446561279	0	0	3.3041726135504996	6.739050417054895	POLR1C;POLR2L
Signal-dependent regulation of myogenesis by corepressor MITR	1/10	0.1310881440726684	0.6285508446561279	0	0	7.87849720223821	16.008202860337175	CAMK1
Calcitonin-like ligand receptors	1/10	0.1310881440726684	0.6285508446561279	0	0	7.87849720223821	16.008202860337175	CALCA
Electron transport reaction in mitochondria	1/10	0.1310881440726684	0.6285508446561279	0	0	7.87849720223821	16.008202860337175	SDHB
Fanconi anemia pathway regulation	1/10	0.1310881440726684	0.6285508446561279	0	0	7.87849720223821	16.008202860337175	UBA52
IRAK2-mediated activation of TAK1 complex	1/10	0.1310881440726684	0.6285508446561279	0	0	7.87849720223821	16.008202860337175	UBA52
Agrin in postsynaptic differentiation	2/47	0.13956537281930567	0.631651239190393	0	0	3.156999598876855	6.216833585412514	DAG1;PAK3
Regulation of transcription by NOTCH1 intracellular domain	2/47	0.13956537281930567	0.631651239190393	0	0	3.156999598876855	6.216833585412514	KAT2A;UBA52
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	2/47	0.13956537281930567	0.631651239190393	0	0	3.156999598876855	6.216833585412514	IRAK1;UBE2V1
Regulated proteolysis of p75 neurotrophin receptor	1/11	0.14321551004652938	0.631651239190393	0	0	7.090287769784172	13.779298717531033	NGFR
SLBP-dependent processing of replication-dependent histone pre-mRNAs	1/11	0.14321551004652938	0.631651239190393	0	0	7.090287769784172	13.779298717531033	SNRPG
Glutathione biosynthesis and recycling	1/11	0.14321551004652938	0.631651239190393	0	0	7.090287769784172	13.779298717531033	GCLM
Mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling	1/11	0.14321551004652938	0.631651239190393	0	0	7.090287769784172	13.779298717531033	MTOR
Class B GPCRs (secretin family receptors)	3/95	0.14724174277206442	0.631651239190393	0	0	2.319116257088847	4.442683551306317	CALCA;WNT9A;GNG12
Amino acid and oligopeptide SLC transporters	2/49	0.14918834405339954	0.631651239190393	0	0	3.022351947154159	5.75016275302209	SLC25A10;SLC3A2
Deadenylation-dependent mRNA decay	2/49	0.14918834405339954	0.631651239190393	0	0	3.022351947154159	5.75016275302209	CNOT6;EIF4A3
M phase pathway	3/96	0.15052481327322534	0.631651239190393	0	0	2.2940626460963065	4.344099737455988	SEC13;CENPF;RPS27
MAPK signaling pathway	7/314	0.15092772301550153	0.631651239190393	0	0	1.627442996742671	3.0774201899456073	ELK4;NTRK1;CASP6;CHP1;HSPB1;PRKX;GNG12
Rab GTPases mark targets in the endocytotic machinery	1/12	0.15517421345640053	0.631651239190393	0	0	6.445389143230869	12.009093108785684	RAB1A
Assembly of HIV virion	1/12	0.15517421345640053	0.631651239190393	0	0	6.445389143230869	12.009093108785684	UBA52
Salmonella infection	1/12	0.15517421345640053	0.631651239190393	0	0	6.445389143230869	12.009093108785684	ARPC1B
Caspase-mediated cleavage of cytoskeletal proteins	1/12	0.15517421345640053	0.631651239190393	0	0	6.445389143230869	12.009093108785684	CASP6
Glutathione metabolism	2/51	0.15893999366564573	0.631651239190393	0	0	2.8986959404700507	5.331364320825576	GSTM1;GCLM
Integrated breast cancer pathway	4/152	0.16339054796400151	0.631651239190393	0	0	1.9236363636363636	3.484882612712878	DAG1;RHO;RAD54L;MTOR
Dilated cardiomyopathy	3/100	0.1638850287087678	0.631651239190393	0	0	2.1990138951142986	3.9771148516444095	DAG1;PRKX;EMD
Integrin-mediated cell adhesion	3/100	0.1638850287087678	0.631651239190393	0	0	2.1990138951142986	3.9771148516444095	RHO;ZYX;PAK3
DNA replication	5/207	0.1640061660700015	0.631651239190393	0	0	1.7632976801329767	3.1877799219866505	SEC13;CENPF;RPS27;POLE3;UBA52
Downregulation of ERBB2-ERBB3 signaling	1/13	0.16696659155380633	0.631651239190393	0	0	5.9079736211031175	10.575045544296069	UBA52
Keap1-Nrf2 pathway	1/13	0.16696659155380633	0.631651239190393	0	0	5.9079736211031175	10.575045544296069	GCLM
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35	1/13	0.16696659155380633	0.631651239190393	0	0	5.9079736211031175	10.575045544296069	NGFR
NICD trafficking to the nucleus	1/13	0.16696659155380633	0.631651239190393	0	0	5.9079736211031175	10.575045544296069	KAT2A
Organic anion transporters	1/13	0.16696659155380633	0.631651239190393	0	0	5.9079736211031175	10.575045544296069	SLC25A10
RNA polymerase II transcription	3/101	0.16727924375312064	0.631651239190393	0	0	2.1764640638864243	3.891715248843477	SNRPG;POLR2J;POLR2L
Melanogenesis	3/101	0.16727924375312064	0.631651239190393	0	0	2.1764640638864243	3.891715248843477	DVL2;PRKX;WNT9A
Protein folding	2/53	0.16880587986380127	0.631651239190393	0	0	2.7847384441141076	4.954066022093192	CCT3;TUBB4B
Activation of Rac	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	PAK3
Polyamine metabolism	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	APIP
Porphyrin metabolism	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	BLVRB
Retrograde neurotrophin signaling	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	NTRK1
Visual signal transduction	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	RHO
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding	1/14	0.17859494938402729	0.631651239190393	0	0	5.453237410071942	9.393937025303781	UBA52
Basal cell carcinoma	2/55	0.1787722570727229	0.631651239190393	0	0	2.679381513520877	4.612937328716323	DVL2;WNT9A
Vibrio cholerae infection	2/55	0.1787722570727229	0.631651239190393	0	0	2.679381513520877	4.612937328716323	ATP6V1G2;PRKX
Pathogenic Escherichia coli infection	2/57	0.18882604867193728	0.631651239190393	0	0	2.5816869051526092	4.303488939256632	ARPC1B;TUBB4B
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	UBA52
Association of licensing factors with the pre-replicative complex	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	UBA52
Calcium signaling by HBx of hepatitis B virus	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	LAMTOR5
Signaling to p38 via RIT and RIN	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	NTRK1
Spliceosomal assembly	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	SNRPG
Stress induction of HSP regulation	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	HSPB1
Coagulation intrinsic pathway	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	SERPING1
TRAF6-mediated induction of TAK1 complex	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	UBA52
TrkA receptor signaling pathway	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	NTRK1
Glycosylation of mammalian N-linked oligosaccarides	1/15	0.19006156011535325	0.631651239190393	0	0	5.063463514902364	8.407411574262907	MAN1C1
Signaling by NGF	5/221	0.19684447097685956	0.631651239190393	0	0	1.6478271154366044	2.678281547514422	NTRK1;NGFR;IRAK1;UBA52;MTOR
Acyl chain remodelling of phosphatidylinositol	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	MBOAT7
B cell survival pathway	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	MTOR
Riboflavin metabolism	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	PHPT1
SREBF and miR-33 in cholesterol and lipid homeostasis	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	MTOR
Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	ELK4
Cell-extracellular matrix interactions	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	RSU1
Sprouty regulation of FGF signaling	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	UBA52
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	UBA52
Interleukin-10 anti-inflammatory signaling pathway	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	BLVRB
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	IRAK1
PI3K subunit p85 role in regulation of actin organization and cell migration	1/16	0.20136866558685315	0.631651239190393	0	0	4.725659472422063	7.573426430446704	ARPC1B
Neurotrophic factor-mediated Trk receptor signaling	2/60	0.20404360833730525	0.631651239190393	0	0	2.4477779160961037	3.890550948953069	NTRK1;NGFR
HIV genome transcription	2/61	0.20914675669245097	0.631651239190393	0	0	2.4061677782536868	3.7649766522922357	POLR2J;POLR2L
mTOR signaling pathway	3/113	0.20945410037317322	0.631651239190393	0	0	1.9378458498023716	3.0293387938403744	RRAGA;BNIP3;MTOR
Oocyte meiosis	3/113	0.20945410037317322	0.631651239190393	0	0	1.9378458498023716	3.0293387938403744	ANAPC13;CHP1;PRKX
ABCA transporters in lipid homeostasis	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	ABCA2
Post-chaperonin tubulin folding pathway	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	TUBB4B
Acyl chain remodelling of phosphatidylserine	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	LPCAT3
Apoptotic cleavage of cellular proteins	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	CASP6
TAK1-mediated activation of p38 MAPK	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	IRAK1
Endocytotic role of NDK, phosphins and dynamin	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	NME2
Estrogen metabolism	1/17	0.21251847664906087	0.631651239190393	0	0	4.430080935251799	6.860983056947853	GSTM1
O-linked glycosylation of mucins	2/63	0.21939063276530033	0.631651239190393	0	0	2.327040303012369	3.529890755935749	GALNT18;B4GALT5
Wnt signaling pathway	5/231	0.22158000458660276	0.631651239190393	0	0	1.57410696983399	2.3721344362368013	PORCN;DVL2;CHP1;PRKX;WNT9A
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.22351317364894482	0.631651239190393	0	0	4.169276343630978	6.2467638903387455	ELK4
Botulinum neurotoxicity	1/18	0.22351317364894482	0.631651239190393	0	0	4.169276343630978	6.2467638903387455	STX2
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.22351317364894482	0.631651239190393	0	0	4.169276343630978	6.2467638903387455	HSPB1
Nucleotide di- and triphosphate biosynthesis and interconversion	1/18	0.22351317364894482	0.631651239190393	0	0	4.169276343630978	6.2467638903387455	NME2
MAPK cascade role in angiogenesis	2/64	0.2245286971889899	0.631651239190393	0	0	2.28939093979271	3.4197817292664148	DAG1;MTOR
HIV life cycle	3/118	0.22767608648481955	0.631651239190393	0	0	1.8531190926275993	2.7423036978903665	UBA52;POLR2J;POLR2L
Signaling by NOTCH	3/119	0.23135686665743957	0.631651239190393	0	0	1.8370502248875562	2.6890628824148215	KAT2A;MIB2;UBA52
Apoptosis modulation by HSP70	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	CASP6
STAT3 pathway	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	MTOR
Signaling by NODAL	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	GDF1
Signaling by constitutively active EGFR	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	UBA52
Cell cycle progression regulation by PLK3	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	CASP6
FRS2-mediated activation	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	NTRK1
GABA biosynthesis, release, reuptake and degradation	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	DNAJC5
Lissencephaly gene (LIS1) in neuronal migration and development	1/19	0.2343549068231997	0.631651239190393	0	0	3.9374500399680255	5.712919565789228	DCTN6
Destabilization of mRNA by AUF1 (hnRNP D0)	2/66	0.23483067789639514	0.631651239190393	0	0	2.2176218411552346	3.2130913160988364	HSPB1;UBA52
4-1BB-dependent immune response	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	MAP4K5
Peroxisomal lipid metabolism	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	FAR2
RNA polymerase III abortive and retractive initiation	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	POLR2L
Apoptotic signaling in response to DNA damage	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	CASP6
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	MTOR
Golgi-associated vesicle biogenesis	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	BLOC1S1
N-glycan antennae elongation in the medial/trans-Golgi	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	B4GALT5
Nerve growth factor (NGF) pathway	1/20	0.24504579671381618	0.631651239190393	0	0	3.7300265051117	5.245574173234264	NGFR
Transcription	4/181	0.24656343446982434	0.631651239190393	0	0	1.6060811504879302	2.248732002317433	POLR1C;SNRPG;POLR2J;POLR2L
PPAR signaling pathway	2/69	0.2503300674358088	0.631651239190393	0	0	2.1180020475241124	2.9333798056380345	FABP7;UCP1
Antiviral mechanism by interferon-stimulated genes	2/70	0.255504275598376	0.631651239190393	0	0	2.086748778933956	2.8474023790439413	EIF4A3;UBA52
CDC42 signaling events	2/70	0.255504275598376	0.631651239190393	0	0	2.086748778933956	2.8474023790439413	ARPC1B;MTOR
Hedgehog signaling pathway	2/70	0.255504275598376	0.631651239190393	0	0	2.086748778933956	2.8474023790439413	PRKX;WNT9A
Long-term potentiation	2/70	0.255504275598376	0.631651239190393	0	0	2.086748778933956	2.8474023790439413	CHP1;PRKX
Presynaptic function of kainate receptors	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	GNG12
Biosynthesis of unsaturated fatty acids	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	PECR
CD28-dependent PI3K/Akt signaling	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	MTOR
E-cadherin keratinocyte pathway	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	ZYX
p38 MK2 pathway	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	HSPB1
Mitochondrial role in apoptotic signaling	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	CASP6
Mitochondrial tRNA aminoacylation	1/21	0.2555879345743658	0.631651239190393	0	0	3.5433453237410073	4.833791870244161	RARS2
Neurotrophin signaling pathway	3/126	0.25740130192435495	0.6333426771033471	0	0	1.7318840579710144	2.3503726324533503	NTRK1;NGFR;IRAK1
Phase II of biological oxidations: conjugation	2/71	0.2606805156048584	0.6386103460887579	0	0	2.056401402186993	2.7647488114358585	GSTM1;GCLM
T cell receptor downstream signaling	1/22	0.26598338276458605	0.643175335047124	0	0	3.3744433025008567	4.468847623560201	UBE2V1
Epstein-Barr virus LMP1 signaling	1/22	0.26598338276458605	0.643175335047124	0	0	3.3744433025008567	4.468847623560201	IRAK1
Fanconi anemia pathway	1/22	0.26598338276458605	0.643175335047124	0	0	3.3744433025008567	4.468847623560201	UBA52
Post-elongation processing of intronless pre-mRNA	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	SNRPG
Proximal tubule bicarbonate reclamation	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	SLC25A10
Downregulation of SMAD2/3-SMAD4 transcriptional activity	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	UBA52
Visual signal transduction: rods	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	RHO
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	HAX1
Modulation of interferon signaling by chaperones	1/23	0.2762341751180707	0.6476871945230984	0	0	3.220896010464356	4.1437030491477325	TAX1BP3
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2/75	0.2813850317536418	0.6476871945230984	0	0	1.9433262449928292	2.4641985587460202	DAG1;EMD
Membrane trafficking	3/133	0.2838171171151416	0.6476871945230984	0	0	1.6380434782608695	2.0629932386051433	SEC13;BLOC1S1;UBA52
SREBP signaling	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	SEC13
TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	IRAK1
Triacylglyceride biosynthesis	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	PNPLA2
Tumor suppressor Arf inhibits ribosomal biogenesis	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	POLR1C
Endogenous Toll-like receptor signaling	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	IRAK1
Lysosome vesicle biogenesis	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	BLOC1S1
NF-kappaB signaling pathway	1/24	0.28634231746557093	0.6476871945230984	0	0	3.0807006568658117	3.8526234091511773	IRAK1
VEGF signaling pathway	2/76	0.2865561064556042	0.6476871945230984	0	0	1.9169675090252707	2.3958661109787234	HSPB1;CHP1
APC/C- and Cdc20-mediated degradation of Nek2A	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	UBA52
Alpha-9 beta-1 integrin pathway	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	TGM2
RNA polymerase I transcription initiation	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	POLR1C
Basigin interactions	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	SLC3A2
C-Myc pathway	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	KAT2A
Cellular response to hypoxia	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	UBA52
Fatty acid biosynthesis	1/25	0.296309787832745	0.6476871945230984	0	0	2.9521882494004794	3.59089356140743	PECR
p73 transcription factor network	2/79	0.3020423569068473	0.6476871945230984	0	0	1.8419991560785784	2.2052193165827743	NTRK1;HAGH
Glycerophospholipid metabolism	2/79	0.3020423569068473	0.6476871945230984	0	0	1.8419991560785784	2.2052193165827743	MBOAT7;LPCAT3
Capped intron-containing pre-mRNA processing	3/138	0.30282690915338983	0.6476871945230984	0	0	1.5769726247987117	1.8838418679930848	SNRPG;POLR2J;POLR2L
Acyl chain remodelling of phosphatidylcholine	1/26	0.30613853694759363	0.6476871945230984	0	0	2.833956834532374	3.354604424996389	LPCAT3
Selenoamino acid metabolism	1/26	0.30613853694759363	0.6476871945230984	0	0	2.833956834532374	3.354604424996389	LCMT1
Glycosaminoglycan biosynthesis: heparan sulfate	1/26	0.30613853694759363	0.6476871945230984	0	0	2.833956834532374	3.354604424996389	HS3ST5
PGC-1a regulation	1/26	0.30613853694759363	0.6476871945230984	0	0	2.833956834532374	3.354604424996389	CAMK1
ADP signalling through P2Y purinoceptor 12	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	GNG12
CTCF pathway	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	MTOR
Collecting duct acid secretion	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	ATP6V1G2
EGFR downregulation	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	UBA52
ERK5 role in neuronal survival pathway	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	NTRK1
eIF4E and p70 S6 kinase regulation	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	MTOR
FSH signaling pathway	1/27	0.315830488654146	0.6476871945230984	0	0	2.7248201438848922	3.1404904694524363	MTOR
Platelet homeostasis	2/82	0.3174701530220889	0.6476871945230984	0	0	1.7726534296028882	2.0338919736247245	KCNMB2;GNG12
Drug metabolism: cytochrome P450	2/83	0.3225959918305012	0.6476871945230984	0	0	1.7506796808842537	1.980639401462082	GSTM1;DHDH
TGF-beta receptor activation of SMADs	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	UBA52
Endosomal sorting complex required for transport (ESCRT) pathway	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	UBA52
G-protein activation	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	GNG12
G-protein beta-gamma signalling	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	GNG12
Nitric oxide stimulation of guanylate cyclase	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	KCNMB2
PKB-mediated events	1/28	0.3253875400567389	0.6476871945230984	0	0	2.623767652544631	2.9458046334546464	MTOR
Interleukin-5 regulation of apoptosis	3/144	0.32571072135805756	0.6476871945230984	0	0	1.509404872032069	1.6931683483063271	TRAP1;IRAK1;ZYX
NOD signaling pathway	2/85	0.3328179991559728	0.6476871945230984	0	0	1.7083206472097778	1.87942516771186	IRAK1;UBE2V1
Pentose and glucuronate interconversions	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	DHDH
Phototransduction	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	RHO
Post-translational modification: biosynthesis of GPI-anchored proteins	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	DPM3
Association of TriC/CCT with target proteins during biosynthesis	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	CCT3
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	CAMK1
T cell receptor calcium pathway	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	CHP1
Thyroid cancer	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	NTRK1
Transferrin endocytosis and recycling	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	ATP6V1G2
Histidine metabolism	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	LCMT1
Homologous recombination	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	RAD54L
Inhibition of insulin secretion by adrenaline/noradrenaline	1/29	0.3348115622311917	0.6476871945230984	0	0	2.5299331963001026	2.768221041975584	GNG12
Progesterone-mediated oocyte maturation	2/86	0.33791273625138674	0.6492090583459862	0	0	1.6878975416881554	1.831314134054701	ANAPC13;PRKX
mRNA stability regulation by proteins that bind AU-rich elements	2/86	0.33791273625138674	0.6492090583459862	0	0	1.6878975416881554	1.831314134054701	HSPB1;UBA52
Activation of kainate receptors upon glutamate binding	1/30	0.3441044002335887	0.6540702216186729	0	0	2.4425700818655423	2.605758625280671	GNG12
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) biosynthesis	1/30	0.3441044002335887	0.6540702216186729	0	0	2.4425700818655423	2.605758625280671	HS3ST5
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	5/280	0.35251842780257214	0.6540702216186729	0	0	1.2903782349037825	1.3454159385512143	IRAK1;EIF4A3;IFI35;UBE2V1;UBA52
Prostaglandin biosynthesis and regulation	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	ANXA5
Alpha-6 beta-4 integrin signaling pathway	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	MTOR
Amino acid transport across the plasma membrane	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	SLC3A2
Signal amplification	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	GNG12
CD28 co-stimulation	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	MTOR
Gluconeogenesis	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	SLC25A10
Inwardly rectifying potassium channels	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	GNG12
Keratan sulfate/keratin metabolism	1/31	0.35326787370848106	0.6540702216186729	0	0	2.361031175059952	2.4567206066843066	B4GALT5
EGFR1 pathway	3/152	0.3562072554325074	0.6572694986689623	0	0	1.4277793988911585	1.4738146323414258	ZYX;ID3;HSPB1
Gap junction pathway	2/90	0.3581675415044632	0.6572694986689623	0	0	1.6108467344929438	1.6539439869070423	PRKX;TUBB4B
Prothrombin activation intrinsic pathway	1/32	0.3623037771690341	0.6572694986689623	0	0	2.2847528428869808	2.3196461723018893	SERPING1
Serotonin HTR1 group and FOS pathway	1/32	0.3623037771690341	0.6572694986689623	0	0	2.2847528428869808	2.3196461723018893	ELK4
Signaling by Robo receptor	1/32	0.3623037771690341	0.6572694986689623	0	0	2.2847528428869808	2.3196461723018893	PAK3
Fibrin clot formation (clotting cascade)	1/32	0.3623037771690341	0.6572694986689623	0	0	2.2847528428869808	2.3196461723018893	SERPING1
Neural crest differentiation	2/91	0.36319704917536244	0.6572694986689623	0	0	1.5926662069525006	1.6130678737353856	RAB4B;DVL2
Integrin signaling pathway	3/155	0.3676054084947451	0.6587320335866865	0	0	1.3993850114416475	1.4004277990349865	ARPC1B;TSPAN17;ZYX
Propanoate metabolism	1/33	0.37121388020800067	0.6587320335866865	0	0	2.21324190647482	2.1932715723710996	SUCLG1
Glucagon signaling in metabolic regulation	1/33	0.37121388020800067	0.6587320335866865	0	0	2.21324190647482	2.1932715723710996	GNG12
Glucagon-type ligand receptors	1/33	0.37121388020800067	0.6587320335866865	0	0	2.21324190647482	2.1932715723710996	GNG12
Negative regulators of RIG-I/MDA5 signaling	1/33	0.37121388020800067	0.6587320335866865	0	0	2.21324190647482	2.1932715723710996	UBA52
Signaling by ERBB4	2/93	0.3732108876273228	0.6587320335866865	0	0	1.557503867973182	1.5350939365229894	UBA52;MTOR
ERBB signaling pathway	2/94	0.37819411020353044	0.6587320335866865	0	0	1.5404959974886203	1.4978977340268624	PAK3;MTOR
Fructose and mannose metabolism	1/34	0.3799999281110667	0.6587320335866865	0	0	2.146064966208851	2.076498586619172	PHPT1
Induction of apoptosis through DR3 and DR4/5 death receptors	1/34	0.3799999281110667	0.6587320335866865	0	0	2.146064966208851	2.076498586619172	CASP6
MAPK/TRK pathway	1/34	0.3799999281110667	0.6587320335866865	0	0	2.146064966208851	2.076498586619172	TRPV1
Toll receptor cascades	3/159	0.3827474468586905	0.6587320335866865	0	0	1.3632246376811594	1.309213561643074	IRAK1;UBE2V1;UBA52
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	2/95	0.3831608266421182	0.6587320335866865	0	0	1.5238538876596406	1.4618337430796304	POLR1C;POLR2L
Transport of inorganic cations/anions and amino acids/oligopeptides	2/95	0.3831608266421182	0.6587320335866865	0	0	1.5238538876596406	1.4618337430796304	SLC25A10;SLC3A2
Prion diseases	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	PRKX
Autophagy regulation	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	ATG4C
Basal transcription factors	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	TAF9B
Base excision repair	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	POLE3
Ether lipid metabolism	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	PAFAH2
fMLP induced chemokine gene expression in HMC-1 cells	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	CAMK1
Interleukin-2/PI3K pathway	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	MTOR
PIK3C1/AKT pathway	1/35	0.3886636419201306	0.6587320335866865	0	0	2.0828396106644096	1.9683687933786107	MTOR
Signaling to ERKs	1/36	0.397206718964544	0.6684246714179762	0	0	2.0232271325796507	1.8680424373346394	NTRK1
Neurotransmitter release cycle	1/36	0.397206718964544	0.6684246714179762	0	0	2.0232271325796507	1.8680424373346394	DNAJC5
Downstream signaling events Of B cell receptor (BCR)	2/98	0.3979569344984029	0.6684246714179762	0	0	1.4760078219013237	1.3600105580609967	UBA52;MTOR
Potassium channels	2/99	0.402852706785387	0.6746279656913495	0	0	1.4607168111950575	1.3280607559768542	KCNMB2;GNG12
Latent infection of Homo sapiens with Mycobacterium tuberculosis	1/37	0.40563083300789615	0.6772586229685409	0	0	1.9669264588329336	1.7747809758231583	ATP6V1G2
TNF-alpha signaling pathway	2/101	0.4125871782919635	0.6809941734285565	0	0	1.431061517704117	1.266929858393561	TRAP1;MAP4K5
Signal transduction through IL-1R	1/38	0.41393763482912255	0.6809941734285565	0	0	1.9136690647482015	1.687932579608778	IRAK1
Cyclin D-associated events in G1	1/38	0.41393763482912255	0.6809941734285565	0	0	1.9136690647482015	1.687932579608778	UBA52
Trefoil factor initiation of mucosal healing	1/38	0.41393763482912255	0.6809941734285565	0	0	1.9136690647482015	1.687932579608778	CASP6
EGFR interaction with phospholipase C-gamma	1/38	0.41393763482912255	0.6809941734285565	0	0	1.9136690647482015	1.687932579608778	NTRK1
Interferon signaling	3/168	0.4164912302040092	0.6826461203797731	0	0	1.288274044795784	1.1283861901677354	EIF4A3;IFI35;UBA52
Signaling by ERBB2	2/102	0.41742504041516143	0.6826461203797731	0	0	1.4166787003610108	1.2376817641037843	UBA52;MTOR
G13 signaling pathway	1/39	0.4221287522472435	0.6826461203797731	0	0	1.863214691404771	1.606920029387674	PAK3
GAB1 signalosome	1/39	0.4221287522472435	0.6826461203797731	0	0	1.863214691404771	1.606920029387674	MTOR
Iron uptake and transport	1/39	0.4221287522472435	0.6826461203797731	0	0	1.863214691404771	1.606920029387674	ATP6V1G2
MHC class II antigen presentation	2/103	0.4222427874719809	0.6826461203797731	0	0	1.4025806912821246	1.2092697334693245	DCTN6;SEC13
Negative regulation of FGFR signaling	1/40	0.4302057905705405	0.6935214037645782	0	0	1.815347721822542	1.5312305581697632	UBA52
Amoebiasis	2/105	0.43181642720235563	0.6941232540416089	0	0	1.375205916371666	1.1548356566059244	HSPB1;PRKX
ERBB1 downstream pathway	2/106	0.43657160111015936	0.6951622230469685	0	0	1.361913357400722	1.1287577163808	ARPC1B;MTOR
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.438170333034661	0.6951622230469685	0	0	1.7698741007194245	1.4604072886294681	UBA52
Tyrosine metabolism	1/41	0.438170333034661	0.6951622230469685	0	0	1.7698741007194245	1.4604072886294681	LCMT1
FOXM1 transcription factor network	1/41	0.438170333034661	0.6951622230469685	0	0	1.7698741007194245	1.4604072886294681	CENPF
Metapathway biotransformation	3/174	0.4386585150777662	0.6951622230469685	0	0	1.2426900584795322	1.0240189076009443	GSTM1;GSTCD;CHST10
Eukaryotic transcription initiation	1/42	0.4460239409022288	0.7008947642749309	0	0	1.7266187050359711	1.3940419843161458	POLR2J
Fatty acid metabolism	1/42	0.4460239409022288	0.7008947642749309	0	0	1.7266187050359711	1.3940419843161458	ACADVL
Netrin-1 signaling	1/42	0.4460239409022288	0.7008947642749309	0	0	1.7266187050359711	1.3940419843161458	SLIT1
Signaling by insulin receptor	2/109	0.4507065160407507	0.7012780559017304	0	0	1.3235264347650055	1.0547696901751875	ATP6V1G2;MTOR
Signaling by interleukins	2/109	0.4507065160407507	0.7012780559017304	0	0	1.3235264347650055	1.0547696901751875	IRAK1;UBE2V1
Porphyrin and chlorophyll metabolism	1/43	0.4537681538187668	0.7012780559017304	0	0	1.685423090099349	1.3317688851841203	BLVRB
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	1/43	0.4537681538187668	0.7012780559017304	0	0	1.685423090099349	1.3317688851841203	DAG1
Cleavage of growing transcript in the termination region	1/43	0.4537681538187668	0.7012780559017304	0	0	1.685423090099349	1.3317688851841203	SNRPG
Insulin secretion regulation by glucagon-like peptide-1	1/43	0.4537681538187668	0.7012780559017304	0	0	1.685423090099349	1.3317688851841203	GNG12
Glycosaminoglycan metabolism	2/110	0.4553735789774847	0.7018257632043102	0	0	1.3112047065115657	1.0314423258086403	HS3ST5;B4GALT5
Signaling by EGFR in cancer	2/111	0.46001786644022474	0.7033910841924512	0	0	1.2991090650150696	1.0087451331535007	UBA52;MTOR
ERBB2/ERBB3 signaling events	1/44	0.4614044901654582	0.7033910841924512	0	0	1.6461435502760582	1.2732594452593304	MTOR
Gastrin pathway	1/44	0.4614044901654582	0.7033910841924512	0	0	1.6461435502760582	1.2732594452593304	CALCA
PI3K events in ERBB2 signaling	1/44	0.4614044901654582	0.7033910841924512	0	0	1.6461435502760582	1.2732594452593304	MTOR
G alpha (z) signaling events	1/45	0.4689344473207568	0.7090895551130582	0	0	1.6086494440810988	1.2182178236895314	GNG12
HNF3B pathway	1/45	0.4689344473207568	0.7090895551130582	0	0	1.6086494440810988	1.2182178236895314	ACADVL
Integrin-linked kinase signaling	1/45	0.4689344473207568	0.7090895551130582	0	0	1.6086494440810988	1.2182178236895314	ZYX
Adaptive immune system	9/606	0.4718933268776761	0.7116455816623019	0	0	1.067783361250698	0.8019077829627	DCTN6;ANAPC13;SEC13;FBXO2;UBE2V1;UBA52;ASB3;TRIM11;MTOR
Polo-like kinase 1 (PLK1) pathway	1/46	0.4763595019907678	0.7145392529861517	0	0	1.5728217426059152	1.166377006847177	RAB1A
Transfer RNA aminoacylation	1/46	0.4763595019907678	0.7145392529861517	0	0	1.5728217426059152	1.166377006847177	RARS2
Vascular smooth muscle contraction	2/116	0.4828884921333072	0.7178441876376854	0	0	1.241813921084299	0.904002680498859	KCNMB2;PRKX
ABC transporters	1/47	0.4836811103868896	0.7178441876376854	0	0	1.5385517672818267	1.117495462385023	ABCA2
Regulation of NFAT transcription factors	1/47	0.4836811103868896	0.7178441876376854	0	0	1.5385517672818267	1.117495462385023	SLC3A2
LKB1 signaling events	1/47	0.4836811103868896	0.7178441876376854	0	0	1.5385517672818267	1.117495462385023	MTOR
Activation of chaperones by IRE1 alpha	1/48	0.4909007086262841	0.7223515578006641	0	0	1.5057400887800398	1.0713542416436928	ACADVL
Post-translational regulation of adherens junction stability and disassembly	1/48	0.4909007086262841	0.7223515578006641	0	0	1.5057400887800398	1.0713542416436928	SLIT1
Intestinal immune network for IgA production	1/48	0.4909007086262841	0.7223515578006641	0	0	1.5057400887800398	1.0713542416436928	IL15RA
p53 activity regulation	2/118	0.49186861868066606	0.7223515578006641	0	0	1.2202788497448027	0.8658410887504964	SHISA5;RPRM
BDNF signaling pathway	4/261	0.4952781464775452	0.7254596349188065	0	0	1.1016059426954368	0.7740277311359594	CENPF;ARPC1B;ZYX;HSPB1
Ceramide signaling pathway	1/49	0.4980197129847964	0.7275756744387261	0	0	1.4742955635491606	1.0277544635382259	NGFR
Aquaporin-mediated transport	1/50	0.505039520072624	0.7303894901701843	0	0	1.4441344883277052	0.986515122945121	GNG12
Type 2 diabetes mellitus	1/50	0.505039520072624	0.7303894901701843	0	0	1.4441344883277052	0.986515122945121	MTOR
Non-coding RNA metabolism	1/50	0.505039520072624	0.7303894901701843	0	0	1.4441344883277052	0.986515122945121	SNRPG
Notch signaling pathway	2/121	0.5051535154831222	0.7303894901701843	0	0	1.1893334951309043	0.8121874053217891	KAT2A;DVL2
Amyloids	1/51	0.5119615071779252	0.7368089248388447	0	0	1.4151798561151079	0.9474711755768047	CALCA
Amino acid metabolism	3/195	0.513404309361416	0.7368089248388447	0	0	1.1055819746376812	0.7370822341877664	APIP;SLC25A10;GCLM
Pyruvate metabolism	1/52	0.5187870326405413	0.7368089248388447	0	0	1.3873606996755536	0.9104718602107987	HAGH
Apoptotic execution  phase	1/52	0.5187870326405413	0.7368089248388447	0	0	1.3873606996755536	0.9104718602107987	CASP6
Taste transduction	1/52	0.5187870326405413	0.7368089248388447	0	0	1.3873606996755536	0.9104718602107987	PRKX
Drug metabolism: other enzymes	1/52	0.5187870326405413	0.7368089248388447	0	0	1.3873606996755536	0.9104718602107987	ITPA
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	1/52	0.5187870326405413	0.7368089248388447	0	0	1.3873606996755536	0.9104718602107987	HS3ST5
G alpha (s) signaling events	2/125	0.5225136489409052	0.7388854173803723	0	0	1.1504211793020458	0.7467431883184137	CALCA;GNG12
Amyotrophic lateral sclerosis (ALS)	1/53	0.525517435890853	0.7388854173803723	0	0	1.360611510791367	0.8753792259141394	CHP1
Thrombin signaling through protease-activated receptors	1/53	0.525517435890853	0.7388854173803723	0	0	1.360611510791367	0.8753792259141394	GNG12
GABA A and B receptor activation	1/53	0.525517435890853	0.7388854173803723	0	0	1.360611510791367	0.8753792259141394	GNG12
HIV infection	3/200	0.5304242905867267	0.7426328737082504	0	0	1.0772456411388214	0.6830578095007958	UBA52;POLR2J;POLR2L
Spliceosome	2/127	0.5310397886829559	0.7426328737082504	0	0	1.131898916967509	0.7163995710573291	EIF4A3;SNRPG
RANKL signaling pathway	1/54	0.5321540378444147	0.7426328737082504	0	0	1.3348717252613005	0.8420668342207889	MTOR
Signaling by FGFR in disease	2/128	0.5352639455814431	0.7451192890103959	0	0	1.1228582889232708	0.7017811503576169	UBA52;MTOR
RNA polymerase I transcription	1/55	0.5386981413171773	0.7461966846393493	0	0	1.3100852651212362	0.810418613488643	POLR1C
Calcineurin-dependent NFAT signaling role in lymphocytes	1/55	0.5386981413171773	0.7461966846393493	0	0	1.3100852651212362	0.810418613488643	CHP1
Messenger RNA processing	3/203	0.5404760146298517	0.7468153798210513	0	0	1.0609239130434782	0.6527918086324658	SNRPG;POLR2J;POLR2L
Cytosolic DNA-sensing pathway	1/56	0.5451510307556662	0.7491509416496805	0	0	1.2862001308044473	0.7803278468839451	POLR1C
Thromboxane A2 receptor signaling	1/56	0.5451510307556662	0.7491509416496805	0	0	1.2862001308044473	0.7803278468839451	TGM2
Phospholipid metabolism	3/205	0.5471084459193851	0.7491509416496805	0	0	1.050312096427034	0.6334518803638705	LPCAT3;MBOAT7;PNPLA2
Acute myeloid leukemia	1/57	0.5515139730861285	0.7491509416496805	0	0	1.2631680369989722	0.7516962722948831	MTOR
Pre-NOTCH expression and processing	1/57	0.5515139730861285	0.7491509416496805	0	0	1.2631680369989722	0.7516962722948831	KAT2A
SHP2 signaling	1/57	0.5515139730861285	0.7491509416496805	0	0	1.2631680369989722	0.7516962722948831	NTRK1
PI3K cascade	1/57	0.5515139730861285	0.7491509416496805	0	0	1.2631680369989722	0.7516962722948831	MTOR
Adipogenesis	2/133	0.5559916539163845	0.7534089803069848	0	0	1.0797255215366384	0.6338010360430588	UCP1;ID3
HIV-1 Nef as negative effector of Fas and TNF	1/58	0.5577882176697552	0.753735136604716	0	0	1.2409440868357946	0.7244332844863288	CASP6
Neuronal system	4/283	0.5589194595856718	0.753735136604716	0	0	1.0135940045617464	0.589658206396067	DNAJC5;KCNMB2;GNG12;STX2
RNA degradation	1/59	0.5639749965259562	0.7569138111269411	0	0	1.2194864797816918	0.6984552239356937	CNOT6
Caspase cascade in apoptosis	1/59	0.5639749965259562	0.7569138111269411	0	0	1.2194864797816918	0.6984552239356937	CASP6
Ubiquitin-mediated proteolysis	2/136	0.5681110166201148	0.7588340007711533	0	0	1.055390915458807	0.5967585797015381	ANAPC13;FBXO2
NGF signaling via TRKA from the plasma membrane	2/136	0.5681110166201148	0.7588340007711533	0	0	1.055390915458807	0.5967585797015381	NTRK1;MTOR
RAGE pathway	1/60	0.5700755246384271	0.7596493333067877	0	0	1.1987562492378978	0.6736847420305989	ID3
Clathrin derived vesicle budding	1/61	0.5760910001045502	0.7611064830106544	0	0	1.1787170263788969	0.6500502338109607	BLOC1S1
Glucose metabolism	1/61	0.5760910001045502	0.7611064830106544	0	0	1.1787170263788969	0.6500502338109607	SLC25A10
Leptin signaling pathway	1/61	0.5760910001045502	0.7611064830106544	0	0	1.1787170263788969	0.6500502338109607	MTOR
Biological oxidations	2/139	0.5799905630984852	0.7611064830106544	0	0	1.0321220585522675	0.5622417269652834	GSTM1;GCLM
T cell receptor signaling pathway	2/139	0.5799905630984852	0.7611064830106544	0	0	1.0321220585522675	0.5622417269652834	CHP1;PAK3
p53 signaling pathway	2/139	0.5799905630984852	0.7611064830106544	0	0	1.0321220585522675	0.5622417269652834	KAT2A;CASP6
Shigellosis	1/62	0.5820226046552063	0.7611064830106544	0	0	1.159334827220191	0.6274853290724507	ARPC1B
Circadian rhythm	1/62	0.5820226046552063	0.7611064830106544	0	0	1.159334827220191	0.6274853290724507	UBA52
Toll-like receptor signaling pathway regulation	2/142	0.5916293797110154	0.7691256173262208	0	0	1.009850438370294	0.530045135669024	IRAK1;SARM1
Collagen biosynthesis and modifying enzymes	1/64	0.5936388454585625	0.7691256173262208	0	0	1.12241635263218	0.5853223362600809	PCOLCE2
Ubiquitin-mediated degradation of phosphorylated Cdc25A	1/64	0.5936388454585625	0.7691256173262208	0	0	1.12241635263218	0.5853223362600809	UBA52
Interferon alpha/beta signaling	1/64	0.5936388454585625	0.7691256173262208	0	0	1.12241635263218	0.5853223362600809	IFI35
ERK1/ERK2 MAPK pathway	1/65	0.5993257640849629	0.7707119863183206	0	0	1.104822392086331	0.5656138039021066	NGFR
Glioma	1/65	0.5993257640849629	0.7707119863183206	0	0	1.104822392086331	0.5656138039021066	MTOR
Interleukin-12-mediated signaling events	1/65	0.5993257640849629	0.7707119863183206	0	0	1.104822392086331	0.5656138039021066	MTOR
Beta-1 integrin cell surface interactions	1/66	0.6049333766441067	0.7707119863183206	0	0	1.087769784172662	0.5467532847308761	TGM2
Signaling by TGF-beta receptor complex	1/66	0.6049333766441067	0.7707119863183206	0	0	1.087769784172662	0.5467532847308761	UBA52
Thyroid-stimulating hormone signaling pathway	1/66	0.6049333766441067	0.7707119863183206	0	0	1.087769784172662	0.5467532847308761	MTOR
HIF-1 transcriptional activity in hypoxia	1/66	0.6049333766441067	0.7707119863183206	0	0	1.087769784172662	0.5467532847308761	BNIP3
Cell cycle	6/453	0.6078425306349491	0.7707119863183206	0	0	0.9476608402782899	0.47178292898226454	ANAPC13;SEC13;CENPF;RPS27;TUBB4B;UBA52
Adipocytokine signaling pathway	1/67	0.6104627852239645	0.7707119863183206	0	0	1.0712339219533464	0.5286945886195664	MTOR
Telomerase regulation	1/67	0.6104627852239645	0.7707119863183206	0	0	1.0712339219533464	0.5286945886195664	MTOR
Actin cytoskeleton regulation	3/226	0.6132399770554912	0.7707119863183206	0	0	0.9503801910703841	0.46473490598774625	ARPC1B;GNG12;PAK3
AMPK signaling	1/68	0.6159150766340925	0.7707119863183206	0	0	1.0551916675614732	0.5113946188282538	MTOR
Activation of NF-kappaB in B cells	1/68	0.6159150766340925	0.7707119863183206	0	0	1.0551916675614732	0.5113946188282538	UBA52
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.6159150766340925	0.7707119863183206	0	0	1.0551916675614732	0.5113946188282538	ATP6V1G2
Calcium regulation in the cardiac cell	2/149	0.6178488489682634	0.7707119863183206	0	0	0.9614185024190182	0.4629340002325188	CAMK1;GNG12
NFAT involvement in hypertrophy of the heart	1/69	0.6212913224752332	0.7707119863183206	0	0	1.0396212441811257	0.4948131254846993	CAMK1
Signaling by the B cell receptor (BCR)	2/151	0.6250993183183765	0.7707119863183206	0	0	0.9484166404186757	0.44560856277399064	UBA52;MTOR
Renal cell carcinoma	1/70	0.62659257975858	0.7707119863183206	0	0	1.0245021374204983	0.47891248095444955	PAK3
Signaling events mediated by HDAC class I	1/70	0.62659257975858	0.7707119863183206	0	0	1.0245021374204983	0.47891248095444955	SIRT2
Complement and coagulation cascades	1/70	0.62659257975858	0.7707119863183206	0	0	1.0245021374204983	0.47891248095444955	SERPING1
Nucleotide metabolism	1/70	0.62659257975858	0.7707119863183206	0	0	1.0245021374204983	0.47891248095444955	NME2
Rac1 cell motility signaling pathway	1/71	0.631819890697657	0.7707119863183206	0	0	1.0098150051387462	0.46365747705062293	ARPC1B
Bacterial invasion of epithelial cells	1/71	0.631819890697657	0.7707119863183206	0	0	1.0098150051387462	0.46365747705062293	ARPC1B
Viral myocarditis	1/71	0.631819890697657	0.7707119863183206	0	0	1.0098150051387462	0.46365747705062293	DAG1
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.631819890697657	0.7707119863183206	0	0	1.0098150051387462	0.46365747705062293	UBL5
Phagosome	2/154	0.6357751630852129	0.7707119863183206	0	0	0.9295553866615999	0.4210052046757722	ATP6V1G2;TUBB4B
Costimulation by the CD28 family	1/72	0.6369742830128208	0.7707119863183206	0	0	0.9955415948930996	0.449015139656258	MTOR
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.6369742830128208	0.7707119863183206	0	0	0.9955415948930996	0.449015139656258	UBA52
Leishmaniasis	1/72	0.6369742830128208	0.7707119863183206	0	0	0.9955415948930996	0.449015139656258	IRAK1
Myocyte adrenergic pathway	1/72	0.6369742830128208	0.7707119863183206	0	0	0.9955415948930996	0.449015139656258	DAG1
Myometrial relaxation and contraction pathways	2/155	0.6392806472003483	0.7707119863183206	0	0	0.9234326703003705	0.4131546025801916	CALCA;GNG12
Carbohydrate metabolism	3/235	0.6395275113408587	0.7707119863183206	0	0	0.9130903298350824	0.408174787984892	SLC25A10;HS3ST5;B4GALT5
Degradation of beta-catenin by the destruction complex	1/73	0.6420567703428891	0.7707119863183206	0	0	0.9816646682653877	0.4349545596431259	UBA52
Myc repressed pathway	1/73	0.6420567703428891	0.7707119863183206	0	0	0.9816646682653877	0.4349545596431259	TMEM126A
RANKL regulation of apoptosis and immune response	1/74	0.6470683521496061	0.7707119863183206	0	0	0.968167931408298	0.42144673937055716	ADAM9
E2F transcription factor network	1/74	0.6470683521496061	0.7707119863183206	0	0	0.968167931408298	0.42144673937055716	KAT2A
Wnt/calcium/cyclic GMP pathway	1/74	0.6470683521496061	0.7707119863183206	0	0	0.968167931408298	0.42144673937055716	WNT9A
Gastric acid secretion	1/74	0.6470683521496061	0.7707119863183206	0	0	0.968167931408298	0.42144673937055716	PRKX
Prolactin activation of MAPK signaling	1/75	0.6520100142964982	0.7749525805515582	0	0	0.9550359712230215	0.40846445144604776	MTOR
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	1/76	0.6568827286269463	0.7790934688366108	0	0	0.9422541966426858	0.39598211099443925	UBA52
G alpha (12/13) signaling events	1/77	0.6616874538011867	0.783136416840645	0	0	0.9298087845513063	0.383975656883125	GNG12
Apoptosis regulation	1/78	0.6664251350197723	0.7843442735426549	0	0	0.9176866299168458	0.37242244439531125	UBA52
Signaling by SCF-KIT	1/78	0.6664251350197723	0.7843442735426549	0	0	0.9176866299168458	0.37242244439531125	MTOR
Pathways in cancer	4/325	0.667251801812635	0.7843442735426549	0	0	0.8790710846785613	0.3556614277062891	NTRK1;DVL2;WNT9A;MTOR
Antigen processing: cross presentation	1/79	0.6710967046354267	0.7843442735426549	0	0	0.9058752997601919	0.3613011454967456	UBA52
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	1/79	0.6710967046354267	0.7843442735426549	0	0	0.9058752997601919	0.3613011454967456	MTOR
Unfolded protein response	1/79	0.6710967046354267	0.7843442735426549	0	0	0.9058752997601919	0.3613011454967456	ACADVL
Nuclear beta-catenin signaling and target gene transcription regulation	1/80	0.6757030818131982	0.7864510972971042	0	0	0.8943629906201621	0.35059165847604884	KCNIP4
Opioid signaling	1/80	0.6757030818131982	0.7864510972971042	0	0	0.8943629906201621	0.35059165847604884	GNG12
MAP kinase signaling pathway	1/81	0.6802451730800891	0.7900984308445756	0	0	0.8831384892086331	0.3402750236493287	MAP4K5
APC/C-mediated degradation of cell cycle proteins	1/82	0.6847238724838143	0.7903911367560078	0	0	0.8721911359801048	0.33033334625688815	UBA52
ATM-dependent DNA damage response	1/82	0.6847238724838143	0.7903911367560078	0	0	0.8721911359801048	0.33033334625688815	DVL2
SMAD2/3 nuclear pathway	1/82	0.6847238724838143	0.7903911367560078	0	0	0.8721911359801048	0.33033334625688815	KAT2A
Class A GPCRs (rhodopsin-like)	3/253	0.6882782423803874	0.7922286363364539	0	0	0.8465652173913043	0.31624468102281983	GPR35;RHO;GPR75
Response to elevated platelet cytosolic calcium	1/83	0.6891400615547051	0.7922286363364539	0	0	0.8615107913669064	0.3207497256405175	SERPING1
Cell junction organization	1/84	0.6934946097102997	0.7923634950050472	0	0	0.851087804455231	0.3115081893481361	RSU1
Differentiation pathway in PC12 cells	1/84	0.6934946097102997	0.7923634950050472	0	0	0.851087804455231	0.3115081893481361	NTRK1
ECM-receptor interaction	1/84	0.6934946097102997	0.7923634950050472	0	0	0.851087804455231	0.3115081893481361	DAG1
TGF-beta regulation of skeletal system development	1/85	0.6977883742452211	0.7924276881610709	0	0	0.8409129838985954	0.30259363278728413	ID3
MicroRNAs in cardiomyocyte hypertrophy	1/85	0.6977883742452211	0.7924276881610709	0	0	0.8409129838985954	0.30259363278728413	MTOR
Myc active pathway	1/85	0.6977883742452211	0.7924276881610709	0	0	0.8409129838985954	0.30259363278728413	KAT2A
Mitotic G2-G2/M phases	1/87	0.706196922600247	0.8003565122802799	0	0	0.82127321398695	0.2856890472983024	TUBB4B
DNA replication pre-Initiation	1/88	0.7103133623698493	0.8015257549442476	0	0	0.8117919457537418	0.27767266454488027	UBA52
HIF-1 degradation in normoxia	1/88	0.7103133623698493	0.8015257549442476	0	0	0.8117919457537418	0.27767266454488027	LAMTOR5
Calcium signaling pathway	2/178	0.7127403272252693	0.8015257549442476	0	0	0.8018132589432229	0.27152453647893665	CHP1;PRKX
Prostate cancer	1/89	0.7143723306098463	0.8015257549442476	0	0	0.8025261608894703	0.26993046158897716	MTOR
Salivary secretion	1/89	0.7143723306098463	0.8015257549442476	0	0	0.8025261608894703	0.26993046158897716	PRKX
Cytokine-cytokine receptor interaction	3/265	0.7179441742275592	0.8028051109119921	0	0	0.8072933952870893	0.2675075365151199	IL15RA;NGFR;CRLF2
Thymic stromal lymphopoietin (TSLP) pathway	1/90	0.7183746268766846	0.8028051109119921	0	0	0.793468595909789	0.2624509113676054	IL15RA
Transmembrane transport of small molecules	5/432	0.7232765849376586	0.8066762706759969	0	0	0.8245440092993043	0.2671222276332184	ABCA2;ATP6V1G2;SLC25A10;SLC3A2;GNG12
Extracellular matrix organization	1/93	0.7300493141820608	0.8119923944241216	0	0	0.7674773224898342	0.2414815156465779	PCOLCE2
TGF-beta signaling pathway	2/185	0.7324693389055854	0.8119923944241216	0	0	0.7708666232664576	0.2399968328918151	TRAP1;EID2
Cell surface interactions at the vascular wall	1/94	0.7338326987041527	0.8119923944241216	0	0	0.7591861994275547	0.23494854723709965	SLC3A2
Fc gamma receptor-mediated phagocytosis	1/94	0.7338326987041527	0.8119923944241216	0	0	0.7591861994275547	0.23494854723709965	ARPC1B
G-protein signaling pathways	1/95	0.7375632457753931	0.8137786565649392	0	0	0.7510714832389408	0.2286287412772396	GNG12
Immune system	12/998	0.7415133255911717	0.8137786565649392	0	0	0.8539781662374365	0.25539254340611495	DCTN6;ANAPC13;SEC13;IRAK1;FBXO2;EIF4A3;IFI35;UBE2V1;UBA52;ASB3;TRIM11;MTOR
Chemokine signaling pathway	2/189	0.7432195801654672	0.8137786565649392	0	0	0.7542230544991216	0.22382605902859362	PRKX;GNG12
Interferon-gamma signaling pathway	1/97	0.7448687584054506	0.8137786565649392	0	0	0.7353492206235012	0.2165950828820162	MTOR
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	1/97	0.7448687584054506	0.8137786565649392	0	0	0.7353492206235012	0.2165950828820162	BNIP3
Insulin signaling pathway	3/277	0.7453829967270922	0.8137786565649392	0	0	0.7714614408124405	0.22669942417732755	PRKX;MAP4K5;MTOR
Transmission across chemical synapses	2/190	0.7458488858514287	0.8137786565649392	0	0	0.7501728243336662	0.21997487655615347	DNAJC5;GNG12
Wnt signaling pathway and pluripotency	1/98	0.7484451641075877	0.8137786565649392	0	0	0.7277312170881851	0.21086546086262303	DVL2
Interleukin-2 signaling pathway	10/847	0.7485022937388746	0.8137786565649392	0	0	0.8387185602679067	0.24296084021427639	NTRK1;TRAP1;TPST1;ID3;BLVRB;TAX1BP3;PRKX;VEZF1;TRPV1;B4GALT5
Senescence and autophagy	1/99	0.751971612935802	0.8143939669053762	0	0	0.7202686830127735	0.20531741713445145	MTOR
Granule cell survival pathway	1/99	0.751971612935802	0.8143939669053762	0	0	0.7202686830127735	0.20531741713445145	POLR2J
GnRH signaling pathway	1/101	0.758877411591791	0.8202894564604909	0	0	0.7057913669064748	0.19473844454014377	PRKX
G alpha (i) signaling events	2/199	0.76849108726731	0.8247434830907244	0	0	0.7155711118034048	0.18842870301913062	RHO;GNG12
Jak-STAT signaling pathway	2/199	0.76849108726731	0.8247434830907244	0	0	0.7155711118034048	0.18842870301913062	IL15RA;CRLF2
Chagas disease	1/104	0.7688785056264685	0.8247434830907244	0	0	0.6851295662499127	0.18006733664935126	IRAK1
Interleukin-4 signaling pathway	1/104	0.7688785056264685	0.8247434830907244	0	0	0.6851295662499127	0.18006733664935126	MTOR
Endocytosis	2/201	0.773278783892699	0.8278805300835957	0	0	0.7083068773470239	0.18211677859827352	NTRK1;ACAP3
Platelet activation, signaling and aggregation	2/205	0.7825961736469169	0.8362599112684197	0	0	0.6942078213085309	0.17017703519494035	SERPING1;GNG12
S phase	1/112	0.7935729772080897	0.8463772627637611	0	0	0.6354916067146283	0.14693187107768607	UBA52
Fas signaling pathway	1/115	0.8021396527934413	0.8538905981349536	0	0	0.6186734822668182	0.13640052372317443	HSPB1
CXCR4 signaling pathway	1/116	0.8049157449068935	0.8552229789635744	0	0	0.6132624335314357	0.1330887854987185	MTOR
Cell cycle checkpoints	1/117	0.8076530240976103	0.8565091616611707	0	0	0.6079446787397668	0.1298708070148402	UBA52
Prolactin regulation of apoptosis	1/118	0.8103520311201674	0.857749980110215	0	0	0.6027178257394085	0.12674343376015756	HAX1
Lipid and lipoprotein metabolism	5/489	0.8154556401417029	0.8600987888749209	0	0	0.7252895578210774	0.1479650565551598	ACADVL;LPCAT3;MBOAT7;FAR2;PNPLA2
Interleukin-1 regulation of extracellular matrix	1/120	0.8156373541558966	0.8600987888749209	0	0	0.5925276585454325	0.12074851063273088	IL15RA
Lysosome	1/121	0.8182247144794621	0.8612083767785708	0	0	0.5875599520383693	0.11787525994070612	ABCA2
Signaling by PDGF	1/122	0.8207758915344251	0.8622757961625702	0	0	0.5826743563826625	0.11508120183783832	MTOR
Innate immune system	3/319	0.8249703477133182	0.8650623646115355	0	0	0.6674807374793615	0.12842852390902507	IRAK1;UBE2V1;UBA52
GPCR ligand binding	4/410	0.826767044907053	0.8652326296045685	0	0	0.6919838781907748	0.13163769202672346	CALCA;RHO;WNT9A;GNG12
Integration of energy metabolism	1/125	0.828217329942341	0.8652326296045685	0	0	0.5684903689951265	0.10714888468560982	GNG12
Axon guidance	3/325	0.8344142715988384	0.8682928612545605	0	0	0.6548406697272482	0.11854270997186768	SLIT1;CHP1;PAK3
HIV factor interactions with host	1/128	0.8353508554943608	0.8682928612545605	0	0	0.5549764912479466	0.09984218886527502	UBA52
Cell-cell communication	1/129	0.8376624820123942	0.8682928612545605	0	0	0.5506126348920863	0.09753553631044946	RSU1
PDGFB signaling pathway	1/129	0.8376624820123942	0.8682928612545605	0	0	0.5506126348920863	0.09753553631044946	ARPC1B
Focal adhesion	2/233	0.8388854381461173	0.8682928612545605	0	0	0.609186240955194	0.10702252570014296	ZYX;PAK3
Signal transduction	11/1020	0.8476389732738782	0.8757375027746697	0	0	0.7611792376077985	0.125823287943302	NTRK1;NGFR;MOB1A;KAT2A;CALCA;ATP6V1G2;IRAK1;MIB2;DVL2;GNG12;MTOR
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	1/135	0.8508686571113948	0.8758482874119128	0	0	0.5257972726296575	0.08491494597763044	NME2
Mitotic G1-G1/S phases	1/135	0.8508686571113948	0.8758482874119128	0	0	0.5257972726296575	0.08491494597763044	UBA52
Diabetes pathways	1/137	0.8550283362190189	0.8769120596323027	0	0	0.5180120609394837	0.0811313954400927	ACADVL
Natural killer cell-mediated cytotoxicity	1/137	0.8550283362190189	0.8769120596323027	0	0	0.5180120609394837	0.0811313954400927	CHP1
EGF/EGFR signaling pathway	1/141	0.8630040304309495	0.8834767537805888	0	0	0.503108941418294	0.07412601756359048	ELK4
SLC-mediated transmembrane transport	2/251	0.8677629184737629	0.8867304139595282	0	0	0.5646267379989272	0.08008481415706445	SLC25A10;SLC3A2
Interleukin-4 regulation of apoptosis	2/267	0.8893702698850982	0.9071576752828001	0	0	0.5301001294189769	0.06214980250628522	CHST10;ID3
Hemostasis pathway	4/468	0.8945659319881156	0.9100217636050386	0	0	0.6036677115987461	0.06725864654250624	KCNMB2;SERPING1;SLC3A2;GNG12
Neuroactive ligand-receptor interaction	2/272	0.8954224839750113	0.9100217636050386	0	0	0.5201497526407274	0.05745554555596438	GPR35;TRPV1
Fatty acid, triacylglycerol, and ketone body metabolism	1/173	0.9129183954083697	0.9261251714721437	0	0	0.40883804584239586	0.037248736839878456	ACADVL
Developmental biology	3/420	0.9347202995880696	0.9465308448897238	0	0	0.503180064643937	0.03396864924675459	SLIT1;GDF1;PAK3
Gastrin-CREB signaling pathway via PKC and MAPK	1/206	0.9454665540388235	0.9556878140824864	0	0	0.3424460431654676	0.019203266405738446	GNG12
Antigen-activated B-cell receptor generation of second messengers	1/211	0.9492032409934105	0.9577392413620562	0	0	0.3342069201781432	0.017422988786069054	CHP1
Generic transcription pathway	2/377	0.9693395791729529	0.9763007251634228	0	0	0.3724861612515042	0.011599325435671246	KAT2A;UBA52
Oncostatin M	1/311	0.9877627406663788	0.9930732930355529	0	0	0.22523787421675562	0.00277329788322552	TGM2
Olfactory transduction	1/432	0.997833006611727	0.9996785624597653	0	0	0.1609941744979886	3.492518617433424E-4	PRKX
Signaling by GPCR	4/977	0.9995127448061717	0.9996785624597653	0	0	0.2802653461646267	1.3659402634633858E-4	CALCA;RHO;WNT9A;GNG12
TGF-beta regulation of extracellular matrix	1/565	0.9996785624597653	0.9996785624597653	0	0	0.12218097862135824	3.927986658162925E-5	ASNA1
